Publications

Adverse events after first COVID-19 vaccination in patients with autoimmune diseases

Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studie

Evolution of anti-modified protein antibody responses can be driven by consecutive exposure to different post-translational modifications

Surface Ig variable domain glycosylation affects autoantigen binding and acts as threshold for human autoreactive B cell activation

ACPA-IgG variable domain glycosylation increases before the onset of rheumatoid arthritis and stabilizes thereafter; a cross-sectional study encompassing 1500 samples

Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients: To wait and repopulate?

Overview of the latest findings on autoantibodies induced via molecular mimicry in the Guillain-Barré syndrome

Aberrant B Cell Receptor Signaling in Naïve B Cells from Patients with Idiopathic Pulmonary Fibrosis

Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis

Flow Cytometric Methods for the Detection of Intracellular Signaling Proteins and Transcription Factors Reveal Heterogeneity in Differentiating Human B Cell Subsets

Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases

Phosphoflow Protocol for Signaling Studies in Human and Murine B Cell Subpopulations

Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study

Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study

Sheathless CE-MS as a tool for monitoring exchange efficiency and stability of bispecific antibodies

A Comparison of Immunoglobulin Variable Region N-Linked Glycosylation in Healthy Donors, Autoimmune Disease and Lymphoma

Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modification

Checkpoints controlling the induction of B cell mediated autoimmunity in human autoimmune diseases

Optimized Protocols for in Vitro T Cell-Dependent and T Cell-Independent Activation for B Cell Differentiation Studies Using Limited Cells

Bruton’s tyrosine kinase inhibition induces rewiring of proximal and distal B-cell receptor signaling in mice

B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells

Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis

lls

Genetic predisposition (HLA-SE) is associated with ACPA-IgG variable domain glycosylation in the predisease phase of RA

MuSK antibodies, lessons learned from poly- and monoclonality

Evolution of anti-modified protein antibody responses can be driven by consecutive exposure to different post-translational modifications

Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational load

Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study

Targeting Bruton’s Tyrosine Kinase in Inflammatory and Autoimmune Pathologies

Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study